Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
- PMID: 33458259
- PMCID: PMC7797511
- DOI: 10.1016/j.bbrep.2020.100892
Evaluation of intestinal microbiota, short-chain fatty acids, and immunoglobulin a in diversion colitis
Abstract
It is reported that an increase in aerobic bacteria, a lack of short-chain fatty acids (SCFAs), and immune disorders in the diverted colon are major causes of diversion colitis. However, the precise pathogenesis of this condition remains unclear. The aim of the present study was to examine the microbiota, intestinal SCFAs, and immunoglobulin A (IgA) in the diverted colon. Eight patients underwent operative procedures for colostomies. We assessed the diverted colon using endoscopy and obtained intestinal samples from the diverted colon and oral colon in these patients. We analyzed the microbiota and SCFAs of the intestinal samples. The bacterial communities were investigated using a 16S rRNA gene sequencing method. The microbiota demonstrated a change in the proportion of some species, especially Lactobacillus, which significantly decreased in the diverted colon at the genus level. We also showed that intestinal SCFA values were significantly decreased in the diverted colon. Furthermore, intestinal IgA levels were significantly increased in the diverted colon. This study was the first to show that intestinal SCFAs were significantly decreased and intestinal IgA was significantly increased in the diverted colon. Our data suggest that SCFAs affect the microbiota and may play an immunological role in diversion colitis.
Keywords: AA, acetic acid; BA, butyric acid; DC, diversion colitis; Diversion colitis; IgA, immunoglobulin A; Immunoglobulin A; Microbiota; OA, organic acid; PA, propionic acid; SCFAs, short-chain fatty acids; Short-chain fatty acids.
© 2020 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors disclose the following: Shuji Terai received research funding from 10.13039/100016567Miyarisan Pharmaceutical Co., Ltd. Asami Matsumoto, Ayaka Minemura, Kentaro Oka and Motomichi Takahashi are employees of Miyarisan Pharmaceutical Co., Ltd.The remaining authors disclose no conflicts. Please note that all Biochemical and Biophysical Research Communications authors are required to report the following potential conflicts of interest with each submission. If applicable to your manuscript, please provide the necessary declaration in the box above.(1)All third-party financial support for the work in the submitted manuscript.(2)All financial relationships with any entities that could be viewed as relevant to the general area of the submitted manuscript.(3)All sources of revenue with relevance to the submitted work who made payments to you, or to your institution on your behalf, in the 36 months prior to submission.(4)Any other interactions with the sponsor of outside of the submitted work should also be reported. (5) Any relevant patents or copyrights (planned, pending, or issued).(6)Any other relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what you wrote in the submitted work. As a general guideline, it is usually better to disclose a relationship than not.
Figures



Similar articles
-
An updated review on the treatment for diversion colitis and pouchitis, with a focus on the utility of autologous fecal microbiota transplantation and its relationship with the intestinal microbiota.Biosci Microbiota Food Health. 2024;43(3):162-169. doi: 10.12938/bmfh.2024-014. Epub 2024 Apr 23. Biosci Microbiota Food Health. 2024. PMID: 38966047 Free PMC article. Review.
-
Utility of autologous fecal microbiota transplantation and elucidation of microbiota in diversion colitis.DEN Open. 2021 Oct 31;2(1):e63. doi: 10.1002/deo2.63. eCollection 2022 Apr. DEN Open. 2021. PMID: 35310733 Free PMC article.
-
Simultaneous determination of six short-chain fatty acids in colonic contents of colitis mice after oral administration of polysaccharides from Chrysanthemum morifolium Ramat by gas chromatography with flame ionization detector.J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Sep 1;1029-1030:88-94. doi: 10.1016/j.jchromb.2016.07.002. Epub 2016 Jul 4. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 27428450
-
Effect of dietary folate level on organ weight, digesta pH, short-chain fatty acid concentration, and intestinal microbiota of weaned piglets.J Anim Sci. 2021 Jan 1;99(1):skab015. doi: 10.1093/jas/skab015. J Anim Sci. 2021. PMID: 33476395 Free PMC article.
-
Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.Scand J Gastroenterol Suppl. 1996;216:132-48. doi: 10.3109/00365529609094568. Scand J Gastroenterol Suppl. 1996. PMID: 8726286 Review.
Cited by
-
Interaction between the intestinal flora and the severity of diversion colitis after low anterior resection of rectal cancer.Front Oncol. 2023 Mar 14;13:1001819. doi: 10.3389/fonc.2023.1001819. eCollection 2023. Front Oncol. 2023. PMID: 36998438 Free PMC article.
-
Successful allogeneic fecal microbiota transplantation for severe diversion colitis: a case report.J Int Med Res. 2024 May;52(5):3000605241241000. doi: 10.1177/03000605241241000. J Int Med Res. 2024. PMID: 38749910 Free PMC article.
-
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.Intest Res. 2024 Jan;22(1):15-43. doi: 10.5217/ir.2023.00080. Epub 2023 Nov 8. Intest Res. 2024. PMID: 37935653 Free PMC article. Review.
-
Small bowel stomas are associated with higher risk of circulating food-specific-IgG than patients with organic gastrointestinal conditions and colostomies.BMJ Open Gastroenterol. 2022 Jul;9(1):e000906. doi: 10.1136/bmjgast-2022-000906. BMJ Open Gastroenterol. 2022. PMID: 35790301 Free PMC article.
-
An updated review on the treatment for diversion colitis and pouchitis, with a focus on the utility of autologous fecal microbiota transplantation and its relationship with the intestinal microbiota.Biosci Microbiota Food Health. 2024;43(3):162-169. doi: 10.12938/bmfh.2024-014. Epub 2024 Apr 23. Biosci Microbiota Food Health. 2024. PMID: 38966047 Free PMC article. Review.
References
-
- Morson B.C., Dawson I.M.P. first ed. Blackwellfic Publications; London: 1972. Gastrointestinal Pathology.
-
- Glotzer D.J., Glick M.E., Goldman H. Proctitis and colitis following diversion of the fecal stream. Gastroenterology. 1981;80:438–441. - PubMed
-
- Korelitz B.I., Cheskin L.J., Sohn N. Proctitis after fecal diversion in Crohn's disease and its elimination with reanastomosis: implications for surgical management. Report of four cases. Gastroenterology. 1984;87:710–713. - PubMed
-
- Szczepkowski M., Kobus A., Borycka K. How to treat diversion colitis? Current state of medical knowledge, own research and experience. Acta Chir. Iugosl. 2008;55:77–81. - PubMed
-
- Ma C.K., Gottlieb C., Haas P.A. Diversion colitis: a clinicopathologic study of 21 cases. Hum. Pathol. 1990;21:429–436. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous